Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial.
Authors: Wintner LM; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: lisa.wintner@i-med.ac.at., Sztankay M; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Abdel-Razeq H; King Hussein Cancer Center, Amman, Jordan., Hamdan-Mansour R; King Hussein Cancer Center, Amman, Jordan., Caocci G; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; Hematology and HSCT Unit, Armando Businco Oncology Hospital, ARNAS G Brotzu, Cagliari, Italy., Mouillet G; Department of Medical Oncology, University Hospital of Besançon, Besançon, France., Kikawa Y; Department of Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan., Shibata N; Department of Breast Surgery, Kansai Medical University Hospital, Hirakata, Japan., Krishnamurthy MN; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Joshi A; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Krishnatry R; Homi Bhabha National Institute, Mumbai, India; Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India., Jain A; Homi Bhabha National Institute, Mumbai, India; Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India., Pappot H; Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Petranović D; Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, Croatia; Department of Internal Medicine, University of Rijeka, Rijeka, Croatia., Trobentar A; Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, Croatia; Faculty of Health Sciences Maribor, University of Maribor, Maribor, Slovenia., Schmidt H; Department for Radiation Medicine, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Schulze S; Krukenberg Cancer Center, University Hospital Halle, Halle (Saale), Germany., Tararykova A; N N Blokhin National Medical Research Center of Oncology, Moscow, Russia., Zabernigg A; Department of Internal Medicine, Kufstein District Hospital, Kufstein, Austria., Giesinger JM; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Holzner B; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
Corporate Authors: EORTC Quality of Life Group
Source: The Lancet. Oncology [Lancet Oncol] 2026 Feb; Vol. 27 (2), pp. 233-242. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(25)00679-5